Revenue and Accounts Receivable (Tables)

9 Months Ended

Mar. 31, 2025

Revenue from Contract with Customer [Abstract]

Summary of Revenues by Payor

Revenues by payor were as follows for the three and nine months ended March 31, 2025 and 2024:


		Three Months Ended								Nine Months Ended
		March 31,								March 31,
		2025				2024				2025				2024
Medicare		$	3,243			$	3,207			$	10,551			$	11,021
Medicaid			1,542				1,506				4,940				4,898
Retail and Institutional Pharmacy			1,958				1,517				5,608				4,839
Private Insurance			561				1,022				1,615				3,179
Self-pay			0				189				408				532
Other			19				21				59				58
Total Net Revenues		$	7,323			$	7,462			$	23,181			$	24,527

Summary of Allowance For Doubtful Accounts

The roll forward of the allowance for credit losses for the three and nine months ended March 31, 2025 and 2024, was as follows:



	Nine Months Ended				Nine Months Ended
	March 31,				March 31,
	2025				2024
June 30, balance	$	240			$	532
Concession allowance expense		61				79
Write-offs		(45	)			(203	)
September 30, balance		256				408
Concession allowance expense		86				67
Write-offs		(110	)			(104	)
December 31, balance		232				371
Concession allowance expense		82				272
Write-offs		(75	)			(363	)
March 31, balance	$	239			$	280